{"@odata.context":"https://ghoapi.azureedge.net/api/$metadata#AMR_INFECT_ECOLI","value":[{"Id":14539,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.6","NumericValue":6.550000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":21024,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60","NumericValue":60.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":33565,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUS","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.3","NumericValue":13.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":37305,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"57.8","NumericValue":57.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1523766,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.2","NumericValue":13.230000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1539796,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.1","NumericValue":80.100000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1582895,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24.9","NumericValue":24.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":1594814,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.3","NumericValue":37.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":1600775,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ISL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12","NumericValue":12.020000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1649732,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.6","NumericValue":12.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1657574,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"36.4","NumericValue":36.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":1672623,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CAN","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"23.4","NumericValue":23.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1697778,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.2","NumericValue":17.240000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":1715546,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.3","NumericValue":6.320000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1745728,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"XKX","ParentLocationCode":null,"TimeDimType":"YEAR","ParentLocation":null,"Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60","NumericValue":60.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1768874,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BGD","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"93.1","NumericValue":93.100000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":1769017,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.1","NumericValue":46.150000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":1809109,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRQ","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"85.7","NumericValue":85.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1813040,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21","NumericValue":20.950000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":1817242,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EGY","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"89.4","NumericValue":89.410000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1817892,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COD","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"72.5","NumericValue":72.550000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1823816,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.7","NumericValue":6.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1824742,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRQ","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"85.5","NumericValue":85.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1863605,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60","NumericValue":60.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1863659,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.4","NumericValue":13.350000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1866609,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LUX","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.3","NumericValue":11.340000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1868118,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MMR","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90.9","NumericValue":90.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1874782,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30","NumericValue":29.980000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1893908,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"14.3","NumericValue":14.310000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1963172,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21.2","NumericValue":21.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2001276,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EGY","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"97.9","NumericValue":97.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2025912,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TLS","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53.8","NumericValue":53.850000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2030663,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.3","NumericValue":15.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2049605,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"59.1","NumericValue":59.060000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2051556,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19","NumericValue":18.980000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2071135,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MMR","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81.3","NumericValue":81.250000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2081836,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"51.7","NumericValue":51.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2118923,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.6","NumericValue":20.640000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2126571,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EGY","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"89.6","NumericValue":89.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2143885,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40.6","NumericValue":40.570000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2146284,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21.5","NumericValue":21.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2158225,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18","NumericValue":18.020000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":2181081,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SGP","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.7","NumericValue":28.690000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2187443,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.4","NumericValue":9.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":2208897,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.3","NumericValue":64.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2235843,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.9","NumericValue":5.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":2259828,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DNK","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.3","NumericValue":7.320000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2276276,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"14.2","NumericValue":14.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":2281228,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.3","NumericValue":20.340000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2283297,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBY","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.3","NumericValue":58.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2288646,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.2","NumericValue":12.180000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2308086,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.9","NumericValue":11.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2332334,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"14.8","NumericValue":14.800000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2343746,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"36.1","NumericValue":36.110000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2348159,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.9","NumericValue":18.940000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":2366899,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COD","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.1","NumericValue":73.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2370473,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"93.5","NumericValue":93.550000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2382528,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.1","NumericValue":64.060000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2383401,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24","NumericValue":23.950000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2385366,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDV","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63","NumericValue":62.960000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2396891,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21.7","NumericValue":21.730000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2406831,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"79.2","NumericValue":79.250000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2418180,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.2","NumericValue":20.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2444781,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"14.4","NumericValue":14.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2463858,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78.8","NumericValue":78.830000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2507359,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"76.5","NumericValue":76.470000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2525123,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.6","NumericValue":7.590000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2526304,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EGY","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"87.8","NumericValue":87.800000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2540438,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"67.7","NumericValue":67.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2565251,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.5","NumericValue":46.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2575070,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ETH","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"100","NumericValue":100.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2607481,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.3","NumericValue":58.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2620436,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.2","NumericValue":7.220000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2628195,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COL","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.6","NumericValue":25.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2639693,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.6","NumericValue":6.620000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2650254,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24.6","NumericValue":24.600000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2689144,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.4","NumericValue":46.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2699881,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.4","NumericValue":20.400000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2720808,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BGD","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90","NumericValue":90.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2723987,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.1","NumericValue":37.100000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2726817,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"56.4","NumericValue":56.410000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2744226,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SGP","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.5","NumericValue":30.480000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2750762,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.8","NumericValue":6.750000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2768878,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"69.2","NumericValue":69.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2831824,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UKR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.9","NumericValue":52.940000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2865885,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MWI","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.9","NumericValue":71.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":2881780,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"22.5","NumericValue":22.470000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2896545,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.1","NumericValue":46.150000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":2897007,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MUS","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.8","NumericValue":58.840000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2898827,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38.8","NumericValue":38.840000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2910081,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78.9","NumericValue":78.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2912582,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"34.4","NumericValue":34.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2917181,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"QAT","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"48.9","NumericValue":48.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2927787,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDG","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.5","NumericValue":45.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2933042,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50.5","NumericValue":50.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2969194,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.7","NumericValue":28.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2976449,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.4","NumericValue":35.370000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2979673,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CMR","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"96.3","NumericValue":96.300000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3004275,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.8","NumericValue":25.790000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3019105,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"55.8","NumericValue":55.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":3021589,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.3","NumericValue":35.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":3022330,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71","NumericValue":71.050000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3045621,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.3","NumericValue":5.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3052970,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"22.9","NumericValue":22.860000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3071588,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EST","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.6","NumericValue":11.570000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3093886,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BGD","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70","NumericValue":70.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":3123095,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.5","NumericValue":11.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3143827,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"66.7","NumericValue":66.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3156034,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.8","NumericValue":30.800000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3170701,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50.8","NumericValue":50.850000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3171293,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.1","NumericValue":37.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3179727,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"32.5","NumericValue":32.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3211347,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.8","NumericValue":7.790000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3239204,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.5","NumericValue":12.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3270673,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.4","NumericValue":11.410000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3273131,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80","NumericValue":80.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3289215,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.8","NumericValue":80.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3305374,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GHA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.8","NumericValue":77.780000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3309357,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.3","NumericValue":10.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3340675,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DZA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"55.4","NumericValue":55.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3356242,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MAR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.9","NumericValue":35.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3364742,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.4","NumericValue":27.370000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3365560,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CMR","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.9","NumericValue":73.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3366990,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81.3","NumericValue":81.250000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3371606,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12","NumericValue":11.980000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3376380,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.7","NumericValue":20.660000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3385491,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.3","NumericValue":20.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3393439,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"65.5","NumericValue":65.540000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":3393705,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.8","NumericValue":52.830000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3408123,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MOZ","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"31.6","NumericValue":31.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3409140,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"32.4","NumericValue":32.390000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3420695,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ETH","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"84.2","NumericValue":84.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3438750,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"22.3","NumericValue":22.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3497973,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KHM","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71","NumericValue":71.030000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3501245,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.6","NumericValue":7.620000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3533205,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.9","NumericValue":35.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3542493,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"41","NumericValue":41.030000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3544145,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LUX","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.9","NumericValue":10.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3548414,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24","NumericValue":24.010000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3568599,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.1","NumericValue":71.100000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3573835,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.5","NumericValue":45.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3604837,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BFA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"88.5","NumericValue":88.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3641412,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.5","NumericValue":77.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3651621,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50.9","NumericValue":50.950000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3662366,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"85.1","NumericValue":85.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3677962,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRQ","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"87.8","NumericValue":87.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3686208,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60.4","NumericValue":60.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3697802,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.7","NumericValue":9.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":3722433,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PER","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"76.7","NumericValue":76.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3733026,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.4","NumericValue":10.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":3744211,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.2","NumericValue":18.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3763615,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.5","NumericValue":16.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3775422,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"51.5","NumericValue":51.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3777846,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.7","NumericValue":27.740000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3794966,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EST","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12","NumericValue":12.010000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3858079,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"47.1","NumericValue":47.060000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3861059,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"XKX","ParentLocationCode":null,"TimeDimType":"YEAR","ParentLocation":null,"Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.5","NumericValue":37.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3862663,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81.8","NumericValue":81.820000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3885987,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LUX","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.7","NumericValue":10.750000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3943584,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"39.7","NumericValue":39.740000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3952103,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"66.7","NumericValue":66.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":3955584,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"36","NumericValue":36.030000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":3964327,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.1","NumericValue":9.070000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4023289,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MWI","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"56.5","NumericValue":56.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4028602,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.8","NumericValue":58.760000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4044933,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"67","NumericValue":67.050000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4048437,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TTO","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"26.3","NumericValue":26.320000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4076808,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.3","NumericValue":52.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":4090339,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.6","NumericValue":77.590000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4091933,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.7","NumericValue":5.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4095054,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.3","NumericValue":8.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":4111518,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.2","NumericValue":18.180000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4123095,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.8","NumericValue":33.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4137575,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63","NumericValue":62.960000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4149437,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"YEM","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"86.4","NumericValue":86.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4151200,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TLS","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.4","NumericValue":30.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4160742,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.4","NumericValue":16.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4224512,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"XKX","ParentLocationCode":null,"TimeDimType":"YEAR","ParentLocation":null,"Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38.5","NumericValue":38.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4244066,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ETH","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"65","NumericValue":65.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4252679,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NGA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.8","NumericValue":80.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4253978,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBR","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40","NumericValue":40.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4262272,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BGD","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"79.2","NumericValue":79.170000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4290785,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.3","NumericValue":16.350000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4300796,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.2","NumericValue":15.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":4325283,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.5","NumericValue":64.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4343734,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.1","NumericValue":27.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4380879,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.4","NumericValue":9.410000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4382601,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.1","NumericValue":8.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4401442,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COL","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.6","NumericValue":28.610000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4415861,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUS","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.4","NumericValue":12.400000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4431894,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50","NumericValue":50.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":4435586,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18","NumericValue":18.020000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4450559,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.1","NumericValue":20.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4475706,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.3","NumericValue":7.310000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4495401,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MMR","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.6","NumericValue":80.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4496022,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KEN","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78","NumericValue":78.050000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4497420,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.3","NumericValue":77.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4504142,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17","NumericValue":17.030000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4562365,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"86.8","NumericValue":86.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4568265,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"39.9","NumericValue":39.930000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4589391,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SGP","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.5","NumericValue":25.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4604299,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"QAT","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"42.3","NumericValue":42.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4655819,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.8","NumericValue":35.760000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4660807,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"57","NumericValue":57.020000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4691036,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.6","NumericValue":33.600000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4708175,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BTN","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"56.8","NumericValue":56.780000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4710001,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KHM","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.7","NumericValue":73.720000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4713242,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UKR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50","NumericValue":50.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4715702,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KEN","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63.6","NumericValue":63.640000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4716455,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"YEM","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90.4","NumericValue":90.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4764365,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UKR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"54.5","NumericValue":54.550000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4782550,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.5","NumericValue":10.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4796702,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEN","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.1","NumericValue":73.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4816139,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.2","NumericValue":37.220000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4832572,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60.9","NumericValue":60.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4848559,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.5","NumericValue":25.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":4860733,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PSE","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.4","NumericValue":45.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4868295,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.6","NumericValue":9.600000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":4870967,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.3","NumericValue":12.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":4893505,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20","NumericValue":20.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":4934643,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RWA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"48","NumericValue":48.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4938067,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MWI","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78.5","NumericValue":78.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":5018775,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.7","NumericValue":7.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5031424,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.7","NumericValue":30.740000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":5058266,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.1","NumericValue":20.120000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":5060126,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.7","NumericValue":10.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5088723,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GHA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.3","NumericValue":64.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5089028,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.4","NumericValue":52.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5092303,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.6","NumericValue":33.610000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":5092854,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.1","NumericValue":9.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5099691,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.4","NumericValue":18.400000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":5121615,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TLS","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.5","NumericValue":61.540000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5173742,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"83.5","NumericValue":83.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5209004,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"69.7","NumericValue":69.730000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5234068,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.4","NumericValue":30.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":5322631,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LUX","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.7","NumericValue":11.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":5348467,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BFA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63.6","NumericValue":63.640000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5400500,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.9","NumericValue":12.880000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":5409043,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.1","NumericValue":13.090000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5412051,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.4","NumericValue":10.440000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":5449462,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEN","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"76.9","NumericValue":76.880000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":5470974,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"86.2","NumericValue":86.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":5510846,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NGA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.2","NumericValue":77.190000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":5521407,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60.8","NumericValue":60.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5526626,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"XKX","ParentLocationCode":null,"TimeDimType":"YEAR","ParentLocation":null,"Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30","NumericValue":30.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5534042,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BTN","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53.9","NumericValue":53.930000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5568059,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"57.3","NumericValue":57.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":5583590,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"88.7","NumericValue":88.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5599229,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.6","NumericValue":9.590000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":5627718,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"55.6","NumericValue":55.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":5682407,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.6","NumericValue":15.600000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5698450,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KWT","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"51.3","NumericValue":51.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5705829,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24","NumericValue":23.970000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5749281,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.6","NumericValue":7.610000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5776460,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MUS","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"49.6","NumericValue":49.590000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5777433,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DNK","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.3","NumericValue":6.310000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5788078,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.7","NumericValue":6.690000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5811787,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.1","NumericValue":11.090000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5817657,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.9","NumericValue":33.860000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":5828121,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"49.5","NumericValue":49.480000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":5829428,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SDN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"66.7","NumericValue":66.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":5843508,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PER","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63.4","NumericValue":63.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":5873426,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.3","NumericValue":10.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":5874657,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.2","NumericValue":17.190000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":5887944,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.4","NumericValue":10.440000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5898706,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.2","NumericValue":16.170000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5933691,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"31.1","NumericValue":31.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5954613,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NAM","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.5","NumericValue":37.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":5955569,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.7","NumericValue":43.650000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5969144,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"85.2","NumericValue":85.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5992314,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"26.8","NumericValue":26.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6019862,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.7","NumericValue":37.660000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6048253,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.6","NumericValue":10.640000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6048784,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HKG","ParentLocationCode":null,"TimeDimType":"YEAR","ParentLocation":null,"Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.1","NumericValue":30.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6082242,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GHA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90.4","NumericValue":90.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6083130,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"23.5","NumericValue":23.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6087765,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.4","NumericValue":73.440000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":6095961,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.1","NumericValue":16.140000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6096739,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"56.4","NumericValue":56.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6104019,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"22.9","NumericValue":22.940000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6118504,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.3","NumericValue":70.250000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6166213,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.7","NumericValue":12.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6168240,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38.9","NumericValue":38.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6176428,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.4","NumericValue":37.400000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6247801,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.8","NumericValue":45.830000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6261346,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.2","NumericValue":73.170000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6271826,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.2","NumericValue":27.170000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6279560,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.6","NumericValue":9.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6288543,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRQ","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"94.9","NumericValue":94.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6300073,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.9","NumericValue":8.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6315415,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.2","NumericValue":8.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6358409,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53.8","NumericValue":53.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":6373438,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MWI","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60","NumericValue":60.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6459578,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"QAT","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.7","NumericValue":46.720000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6460200,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.9","NumericValue":61.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6472438,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"44","NumericValue":44.030000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6477098,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EST","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.9","NumericValue":7.860000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6489588,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.6","NumericValue":35.620000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6495488,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11","NumericValue":10.950000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6516470,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"51.2","NumericValue":51.220000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6567041,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19.8","NumericValue":19.760000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6577663,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COD","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"69","NumericValue":68.970000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6586182,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.5","NumericValue":45.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6595520,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BFA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.8","NumericValue":80.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6607571,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KWT","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.5","NumericValue":45.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6619851,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TZA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"75","NumericValue":75.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6663226,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.5","NumericValue":58.470000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6666899,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.3","NumericValue":11.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":6691926,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DNK","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.3","NumericValue":6.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6698933,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KEN","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.2","NumericValue":77.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6709263,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PER","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.7","NumericValue":71.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6727938,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PSE","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.2","NumericValue":46.230000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6730792,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53","NumericValue":52.970000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6733054,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.4","NumericValue":35.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6735669,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UKR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60","NumericValue":60.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6785812,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.6","NumericValue":52.610000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6820148,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TZA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78","NumericValue":77.980000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6833279,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.9","NumericValue":15.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6833588,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KHM","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.5","NumericValue":73.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6840926,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBY","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.5","NumericValue":61.540000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6852838,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TLS","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50","NumericValue":50.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6865539,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUS","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.5","NumericValue":12.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6874593,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.6","NumericValue":15.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":6923607,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EGY","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"87.5","NumericValue":87.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6929728,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.1","NumericValue":9.060000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":6958844,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TZA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.1","NumericValue":70.150000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6984250,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KHM","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"72.8","NumericValue":72.800000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6988715,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MMR","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"84.9","NumericValue":84.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7018938,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.3","NumericValue":33.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7023332,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.4","NumericValue":9.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7045749,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"57.2","NumericValue":57.230000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7061750,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDV","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.4","NumericValue":70.370000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7076343,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PNG","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.7","NumericValue":35.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7093740,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"75.1","NumericValue":75.110000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":7094761,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.1","NumericValue":5.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7099694,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TZA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"68.7","NumericValue":68.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7109702,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDG","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.3","NumericValue":33.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7114666,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"75.6","NumericValue":75.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7116220,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MOZ","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40","NumericValue":40.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7143938,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BTN","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.6","NumericValue":80.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7160662,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.4","NumericValue":16.370000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7170568,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.1","NumericValue":46.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":7172286,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63","NumericValue":63.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":7179965,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50","NumericValue":50.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7186989,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"85.7","NumericValue":85.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7211456,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.5","NumericValue":16.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7246124,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30","NumericValue":30.040000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7247064,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BFA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"91.7","NumericValue":91.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7297276,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19.8","NumericValue":19.790000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7361022,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DNK","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.3","NumericValue":7.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7372071,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.2","NumericValue":10.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7408804,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.9","NumericValue":18.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7412690,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.8","NumericValue":10.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7434850,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73","NumericValue":72.970000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7441204,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63.9","NumericValue":63.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7444190,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.2","NumericValue":43.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7484462,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.2","NumericValue":52.180000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7488453,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TTO","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.8","NumericValue":27.780000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7519475,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MWI","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"84.2","NumericValue":84.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7558929,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.1","NumericValue":18.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":7559203,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"48.4","NumericValue":48.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7559205,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.3","NumericValue":17.300000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7596420,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81.8","NumericValue":81.820000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7599508,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11","NumericValue":10.970000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7601921,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.9","NumericValue":71.930000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7660426,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.4","NumericValue":15.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":7662786,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ETH","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81","NumericValue":80.950000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7669921,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40.3","NumericValue":40.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":7671266,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.8","NumericValue":9.780000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7675211,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"54.1","NumericValue":54.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7752965,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.6","NumericValue":25.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7766286,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LUX","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.7","NumericValue":15.650000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":7785435,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NGA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81.6","NumericValue":81.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7828048,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.9","NumericValue":7.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7840741,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.2","NumericValue":9.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":7840926,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MAR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"44.7","NumericValue":44.740000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7842571,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.8","NumericValue":18.830000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7845436,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.7","NumericValue":28.660000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7913951,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.4","NumericValue":20.390000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7931110,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.8","NumericValue":61.760000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7997631,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MAR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.1","NumericValue":46.070000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8036496,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ISL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.8","NumericValue":9.790000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8065660,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PSE","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"44.2","NumericValue":44.220000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8068246,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"65.3","NumericValue":65.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8096771,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.1","NumericValue":8.140000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8107931,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"26.1","NumericValue":26.090000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8116209,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"48.5","NumericValue":48.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":8122526,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"54.8","NumericValue":54.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":8136668,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.4","NumericValue":7.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":8146178,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.7","NumericValue":8.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8194291,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.7","NumericValue":6.660000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":8219232,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NGA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"72.7","NumericValue":72.730000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8251482,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.2","NumericValue":18.240000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8251918,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ETH","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"86.2","NumericValue":86.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8257312,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"36.6","NumericValue":36.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8260278,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.1","NumericValue":73.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":8274023,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SGP","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"23.8","NumericValue":23.760000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8298412,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50.9","NumericValue":50.850000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":8328908,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.1","NumericValue":77.060000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8331582,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.4","NumericValue":77.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8339114,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"39.4","NumericValue":39.400000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8353369,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53.8","NumericValue":53.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8428049,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.6","NumericValue":70.640000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8430081,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"54.7","NumericValue":54.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8434530,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDG","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40.5","NumericValue":40.540000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8438077,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19.3","NumericValue":19.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":8464920,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COL","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.8","NumericValue":30.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8468542,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19.6","NumericValue":19.620000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":8470629,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KWT","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53","NumericValue":52.960000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8492219,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.2","NumericValue":28.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8503454,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.9","NumericValue":61.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":8508342,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"QAT","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.3","NumericValue":43.310000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8529770,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40.5","NumericValue":40.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8556136,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63.4","NumericValue":63.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8559156,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.5","NumericValue":12.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8561098,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.8","NumericValue":9.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8631724,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24.5","NumericValue":24.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8638861,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"39.6","NumericValue":39.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":8639586,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CAN","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.4","NumericValue":17.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8753102,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50","NumericValue":50.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8770963,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"55.3","NumericValue":55.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8801220,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PSE","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"47.4","NumericValue":47.370000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8806709,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38.7","NumericValue":38.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8816739,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MMR","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.8","NumericValue":77.780000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8821858,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.3","NumericValue":7.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":8822648,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.7","NumericValue":16.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":8828414,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.2","NumericValue":10.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":8832809,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"82.3","NumericValue":82.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8841706,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.1","NumericValue":6.140000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":8868945,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.4","NumericValue":10.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8877260,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CIV","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90","NumericValue":90.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8880675,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MUS","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60.4","NumericValue":60.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8931088,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"88.2","NumericValue":88.240000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8960691,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.3","NumericValue":58.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8975037,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60.5","NumericValue":60.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8998368,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"QAT","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40","NumericValue":40.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":9027001,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KWT","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.7","NumericValue":43.660000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9028899,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.3","NumericValue":10.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9032335,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"41.7","NumericValue":41.720000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9033275,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.8","NumericValue":9.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9049812,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NAM","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.2","NumericValue":18.180000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9056442,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9","NumericValue":8.960000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9063429,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"48.1","NumericValue":48.070000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9069806,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.2","NumericValue":28.240000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":9078722,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KHM","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.1","NumericValue":71.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9108657,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PER","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.7","NumericValue":58.730000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9119855,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78.2","NumericValue":78.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9137730,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.3","NumericValue":45.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9139453,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.9","NumericValue":28.860000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9151446,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7","NumericValue":6.990000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9159475,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"59.3","NumericValue":59.340000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9173131,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"57.1","NumericValue":57.140000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9211902,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21.3","NumericValue":21.340000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9213425,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.3","NumericValue":8.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9224017,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38.6","NumericValue":38.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":9224750,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CMR","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70","NumericValue":70.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9229602,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.3","NumericValue":52.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9256655,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"69.2","NumericValue":69.230000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":9266596,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"88.9","NumericValue":88.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9289498,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.3","NumericValue":70.320000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9313662,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"65.3","NumericValue":65.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":9323806,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"26.5","NumericValue":26.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9335641,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.6","NumericValue":64.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9377635,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38","NumericValue":38.020000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":9409538,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.3","NumericValue":13.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9418124,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19.6","NumericValue":19.570000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9427379,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.5","NumericValue":17.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9430541,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.1","NumericValue":70.140000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9462633,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.9","NumericValue":61.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":9493731,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"72.1","NumericValue":72.120000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9508331,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.8","NumericValue":27.790000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":9512785,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CIV","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"75","NumericValue":75.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9527804,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","ParentLocationCode":"AMR","TimeDimType":"YEAR","ParentLocation":"Americas","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"36.3","NumericValue":36.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9547644,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.7","NumericValue":27.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9549377,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HKG","ParentLocationCode":null,"TimeDimType":"YEAR","ParentLocation":null,"Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.5","NumericValue":30.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9585638,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.5","NumericValue":17.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":9589022,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.9","NumericValue":43.890000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9605448,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.9","NumericValue":8.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9628438,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MUS","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.7","NumericValue":52.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9630112,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"51.6","NumericValue":51.610000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":9675171,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.6","NumericValue":11.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":9731911,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUS","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2020,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.4","NumericValue":13.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":9741406,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.6","NumericValue":5.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":9746378,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.6","NumericValue":17.600000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":9747867,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.2","NumericValue":6.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9792563,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"32","NumericValue":32.050000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":9793546,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.6","NumericValue":43.590000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9799682,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.2","NumericValue":10.220000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9814292,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDA","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.9","NumericValue":71.880000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9815798,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.3","NumericValue":18.300000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9833736,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MOZ","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28","NumericValue":28.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9836012,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"56.6","NumericValue":56.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9848046,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13","NumericValue":13.040000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9849737,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90","NumericValue":90.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9877311,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","ParentLocationCode":"SEAR","TimeDimType":"YEAR","ParentLocation":"South-East Asia","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.4","NumericValue":80.390000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9877695,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SYR","ParentLocationCode":"EMR","TimeDimType":"YEAR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78.6","NumericValue":78.570000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9878957,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21.9","NumericValue":21.930000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9899046,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2019,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.5","NumericValue":5.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9908719,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SGP","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2021,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.8","NumericValue":25.830000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9924623,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUS","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.7","NumericValue":12.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9931182,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2016,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"22.7","NumericValue":22.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":9943392,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MOZ","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.3","NumericValue":64.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9947219,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","ParentLocationCode":"WPR","TimeDimType":"YEAR","ParentLocation":"Western Pacific","Dim1Type":null,"TimeDim":2018,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.9","NumericValue":71.880000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":9957676,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2017,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.9","NumericValue":15.890000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9968163,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GHA","ParentLocationCode":"AFR","TimeDimType":"YEAR","ParentLocation":"Africa","Dim1Type":null,"TimeDim":2023,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90.6","NumericValue":90.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":10002443,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","ParentLocationCode":"EUR","TimeDimType":"YEAR","ParentLocation":"Europe","Dim1Type":null,"TimeDim":2022,"Dim1":null,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.8","NumericValue":18.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"}]}